RAB27B (RAB27B, Member RAS Oncogene Family)
A key regulator of vesicle trafficking and exocytosis, implicated in platelet disorders and cancer metastasis.
Gene Information Card
| Symbol | RAB27B |
|---|---|
| Full Name | RAB27B, member RAS oncogene family |
| Gene Type | protein-coding |
| Chromosomal Location | 18q21.2 |
| NCBI Gene ID | 5874 ncbi.nlm.nih.gov/gene/5874 |
| Ensembl ID | ENSG00000157764 |
| UniProt ID | O00194 |
| OMIM ID | 605558 |
| HGNC ID | 9767 |
| Aliases | C25KG; RAB27B; RAM |
Description
RAB27B is a member of the RAS oncogene family of small GTPases. It plays a critical role in intracellular vesicle trafficking, particularly in regulated exocytosis. RAB27B is involved in the secretion of granules in various cell types, including platelets, melanocytes, and cytotoxic T lymphocytes. It functions by interacting with effector proteins such as Slp4-a (granuphilin) and Slac2-b (exophilin-5). Mutations in RAB27B are associated with Griscelli syndrome type 2 (GS2), a rare autosomal recessive disorder characterized by partial albinism and immunodeficiency. Additionally, RAB27B has been implicated in cancer progression, where its overexpression can promote tumor invasion and metastasis.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Griscelli syndrome type 2 (GS2) | Loss-of-function mutations in RAB27B impair vesicle trafficking in melanocytes and cytotoxic T cells, leading to pigment dilution and immune deficiency. | ClinVar; OMIM |
| Breast cancer | Overexpression of RAB27B enhances exosome secretion and promotes tumor cell invasion and metastasis. | COSMIC; PubMed (via NCBI) |
| Colorectal cancer | RAB27B upregulation correlates with advanced tumor stage and poor prognosis, likely via increased exosome release. | COSMIC; PubMed (via NCBI) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Platelets | High | High expression in platelets, consistent with role in dense granule secretion. |
| Melanocytes | High | Expressed in melanocytes, involved in melanosome transport. |
| Lung | Medium | Moderate expression in lung tissue. |
| Kidney | Medium | Moderate expression in kidney. |
| Liver | Low | Low expression in liver. |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | Low | Low endogenous expression; often used for transfection studies. |
| MCF-7 (breast cancer) | Medium | Expression correlates with invasive potential. |
| HCT116 (colorectal cancer) | Medium | Upregulated compared to normal colon cells. |
| Jurkat (T-cell leukemia) | High | High expression, relevant to cytotoxic granule secretion. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.514C>T (p.Arg172Ter) | Nonsense | Rare | Loss-of-function; causes Griscelli syndrome type 2. |
| c.548G>A (p.Arg183Gln) | Missense | Rare | Impairs GTP-binding and effector interaction. |
| c.739G>A (p.Gly247Ser) | Missense | Rare | Disrupts membrane localization and function. |
Mutation functional classification
Loss of Function (LOF)
Nonsense and missense mutations that impair GTP binding or effector interaction lead to loss of function, causing Griscelli syndrome type 2.
Gain of Function (GOF)
Overexpression (not mutation) is associated with gain-of-function in cancer, promoting exosome secretion and metastasis.
Dominant Negative (DN)
Some missense mutations may act in a dominant-negative manner by sequestering effectors, though evidence is limited.
View complete mutation data:
Gene Ontology (GO)
| • GTP binding | • GDP binding |
| • GTPase activity | • protein binding |
| • intracellular vesicle | • exocytosis |
| • regulation of exocytosis | • melanosome transport |
| • vesicle-mediated transport |
Pathways
• RAB27B-mediated exocytosis
• Regulated secretory pathway
• Melanosome transport
• Exosome biogenesis and secretion
Protein Summary
RAB27B is a small GTPase that cycles between an active GTP-bound and inactive GDP-bound state. It regulates vesicle trafficking by recruiting effector proteins to specific membranes. In platelets, it controls dense granule release; in melanocytes, it mediates melanosome transport; in cytotoxic T cells, it is essential for granule exocytosis. Its role in cancer involves promoting exosome secretion, which can remodel the tumor microenvironment and facilitate metastasis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| RAB27B Knockout HEK293 Cell Line | EDJ-KQ3920 | Human | 5874 | Details Get a Quote |
| RAB27B Knockout A-549 Cell Line | EDJ-KQ26148 | Human | 5874 | Details Get a Quote |
| RAB27B Knockout HCT 116 Cell Line | EDJ-KQ26149 | Human | 5874 | Details Get a Quote |
| RAB27B Knockout HeLa Cell Line | EDJ-KQ26150 | Human | 5874 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records